Gastroenterology Expert Column

 
 

Gastroenterology Expert Column

  • Obscure Gastrointestinal Bleeding -- The Role of Endoscopy Obscure gastrointestinal bleeding is defined as bleeding of unknown origin that persists or recurs after an initial negative endoscopic evaluation including colonoscopy and/or upper endoscopy.
  • Epidemiology of Hepatitis B -- Clinical Implications Jacob Alexander, MD, and Kris V. Kowdley, MD, FACP, explore the latest information regarding HBV, ranging from geographic distribution to issues in transmission and genotyping.
  • Chronic Hepatitis B -- Who Should Be Treated? The authors discuss criteria for determining when and how to most effectively intervene with antiviral therapy for chronically infected patients.
  • Noninvasive Diagnosis of Liver Fibrosis in Patients With CHC The prognosis and management of chronic liver diseases greatly depends on the degree and progression of liver fibrosis. Until recently, liver biopsy was the only way to evaluate fibrosis in the liver.
  • Atypical Manifestations of Gastroesophageal Reflux Disease GERD may manifest typically with heartburn and regurgitation or atypically as laryngitis, asthma, cough, or noncardiac chest pain. Diagnosis of these atypical manifestations may be difficult.
  • Probiotics in the Management of Inflammatory Bowel Disease Richard N. Fedorak, MD, FRCPC, and colleague explore the current state of the field regarding applications of probiotic therapy in the settings of Crohn's disease, ulcerative colitis, and pouchitis.
  • EUS-FNA in Diagnosis and Staging of Pancreatic Adenocarcinoma EUS has become an important tool in the armamentarium of gastroenterologists for the diagnosis and staging of pancreatic neoplasms.
  • Techniques for Difficult Polypectomy What constitutes a difficult polyp? What additional techniques facilitate the difficult polypectomy? Douglas B. Nelson, MD, explores the current state of the field.
  • IBD and Pregnancy Sunanda V. Kane, MD, and colleague, review the state of the field regarding the effects of IBD and its treatment on fertility and pregnancy.
  • Endoluminal Treatment of GERD -- Role in Clinical Practice John K. DiBaise, MD, FACG, and colleague, discuss technique and safety and efficacy data for the endoscopic therapies for GERD, with a view toward their potential role in the current armamentarium.
  • The Role of Interferon Therapy in Hepatitis B W. Graham E. Cooksley, MD, explores the place that interferon currently holds in the therapeutic armamentarium against hepatitis B.
  • Nonalcoholic Fatty Liver Disease Arun J. Sanyal, MD, and colleague discuss the risk factors, clinical signs, diagnosis, and treatment of this common cause of chronic liver disease.
  • Chronic Pancreatitis Darwin L. Conwell, MD, and colleagues discuss this chronic inflammatory condition, which remains a major source of morbidity in the United States.
  • Functional Dyspepsia Brooks D. Cash, MD, discusses the approach to the patient with nonulcer dyspepsia.
  • Genetics of IBD Jean-Paul Achkar, MD, and Bret A. Lashner, MD, address the molecular aspects of IBD.
  • Treatment of Hepatitis C Emmet B. Keeffe, MD, discusses the current state of the field in HCV management.
  • Expert Column - Treatment of Perianal Crohn's Disease David A. Schwartz, MD, and William J. Sandborn, MD, of the Mayo Clinic discuss the options available for medical management of this disease entity.